DigiQure

Akanksh Tandon is Season 2's most personally loss-motivated healthcare founder a village-born NIT Bhopal graduate who had already cleared the PSU exam and taken a government job before abandoning security to build DigiQure, because watching his house help's young daughter die of diarrhea a completely preventable condition while rural families had no access to the specialist doctors who could have saved her, was a personal trauma he could not leave unaddressed. DigiQure was founded by three NIT-Bhopal graduates in 2020. It establishes telemedicine-based e-clinics where 'caregivers' trained healthcare workers facilitate video consultations with specialist doctors. It also offers digital prescriptions, medicines, lab test services, and required referrals to partner hospitals for secondary care.

The founders asked the Sharks: do they know that when someone from Delhi, Mumbai, or Bengaluru falls sick, they do not get really worked up, because they have access to the best doctors, hospitals, and healthcare facilities. But on the other hand, when someone from a small town falls sick, they have no one to help them. Many people have lost family members due to this reason. Around 24 lakh people lose their lives due to preventable healthcare conditions. The founders came up with its solution through their healthcare revolution DigiQure E-Clinic. DigiQure is India's most practically deployable rural telemedicine e-clinic brand physically establishing small clinic spaces in rural towns (staffed by trained caregivers), connecting patients to specialist doctors in cities through video consultation technology, providing digital prescriptions, medicine delivery, lab tests, and referrals for secondary care, all accessible to the poorest patients through the Saksham Card's ₹1/day unlimi

Amount Asked: ₹40 lakhs Equity Offered: 4% Implied Pre-Money Valuation: ₹10 crore

Akanksh and Soumen opened Season 2 Episode 31 with the most personally motivated rural healthcare pitch in Season 2 asking the Sharks directly whether they knew the difference between getting sick in Delhi versus getting sick in a village, then answering their own question with the statistic that 24 lakh Indians die annually from preventable healthcare conditions because specialist doctors simply cannot be found within 50 to 100 km. The founding story Akanksh's house help's daughter dying of diarrhea while they watched helplessly because no accessible specialist was available was Season 2 Episode 31's most personally heartbreaking origin moment. The emotional weight was not performance; the founder had carried this specific loss as his primary professional motivation.

Aman Gupta was the first to exit expressing doubt about the business's profitability despite supporting its social purpose. Vineeta Singh co-offered with Namita appreciating the social mission but ultimately deferring to Namita's pharmaceutical industry domain expertise for the deeper engagement. Anupam Mittal was the most philosophically engaged Shark noting that telemedicine had historically failed in India but believed the timing was now right. Peyush Bansal made the largest capital offer ₹1 crore for 25% equity, solo, under the same merger condition. Namita Thapar was the most domain-aligned Shark her Emcure Pharmaceuticals expertise in rural healthcare distribution, medicine supply chains, and government health programme partnerships made her the most strategically valuable investor for DigiQure's specific model.

Namita and Vineeta gave an offer of ₹40 lakhs for 20% at ₹2 crores valuation. Peyush gave the offer of ₹1 crore for 25% equity. Anupam offered ₹1 crore for 10% equity (matching the founders' dream deal). Namita then revised her offer to ₹40 lakhs for 15% equity. The founders countered Namita's last offer with ₹40 lakhs for 10% equity which she accepted, leading to a handshake. DigiQure got a deal from shark Namita Thapar of ₹40 lakhs for 10% equity at a valuation of ₹4 crore. After pitchers left, Peyush said they had literally killed their business by partnering with a medical firm.

Akanksh Tandon and Soumen Banerjee accepted Namita Thapar's offer of ₹40 lakhs for 10% equity valuing DigiQure at ₹4 crore. They chose Namita's offer over Anupam's dream-deal (₹1 crore for 4% at ₹25 crore valuation) and Peyush's offer (₹1 crore for 25%) specifically because Namita's pharmaceutical and healthcare distribution network was the most directly applicable to DigiQure's rural healthcare supply chain and medicine delivery requirements. The deal was confirmed and formally closed after the episode aired.

Our research in the company revealed that their Shark Tank India Deal with Namita did indeed close after the show aired. Company also partnered up with another one of Namita's Shark Tank investments AyuSynk to get their medical devices into their e-clinics along with another Shark Tank-appeared device Spandan from Sunfox Technologies. They have also expanded to 5 cities across India and as of November 2023, the company is still in business and growing. The AyuSynk partnership integrating the digital stethoscope into DigiQure's e-clinics created exactly the kind of cross-portfolio synergy that Namita's investment was intended to enable. Two Shark Tank Season 2 investments from the same Shark creating a commercial partnership demonstrates the network leverage that multi-investment Shark portfolios can generate.